Seattle, Washington, United States
Molecular Testing Labs® is passionate about bridging the gap and building bonds between the large communities that have access to diagnostics and the smaller underserved communities that deserve that same access. Our icon circles represent those large and small communities. We are visionaries in our approach to precision lab diagnostics and are committed to revolutionizing accessibility via technology, logistics, and cutting-edge research and development. We are pioneering and innovating distinctive distribution and specimen collection methods that open access to medical testing where geographic, financial, and stigma barriers once created gaps in the healthcare industry. We provide accessible and innovative laboratory solutions through collaborative partnerships with payors, private healthcare institutions, universities, commercial partners, and public health organizations. Molecular Testing Labs® is a CLIA and CAP accredited, state-of-the-art, esoteric and reference laboratory. We specialize in high-complexity, molecular testing with an extensive portfolio of services including infectious disease, toxicology, targeted sequencing, single nucleotide polymorphism (SNP) genotyping, Next-Generation Sequencing (NGS), and high-resolution immune profiling. Molecular Testing Labs® offers a variety of clinical trial services comprising of assay development, trial site training, investigator support, and customized reporting. We apply the maximum level of control to obtain the most consistent and highest quality results. Molecular Testing Labs® is founded on three guiding principles – Compliance, Innovation and Partnership. For more information, please visit our corporate website – www.moleculartestinglabs.com.
Responsible for managing 16 Direct Reports